1. Home
  2. RDHL vs SGD Comparison

RDHL vs SGD Comparison

Compare RDHL & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • SGD
  • Stock Information
  • Founded
  • RDHL 2009
  • SGD 2021
  • Country
  • RDHL Israel
  • SGD United States
  • Employees
  • RDHL N/A
  • SGD N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • SGD
  • Sector
  • RDHL Health Care
  • SGD
  • Exchange
  • RDHL Nasdaq
  • SGD Nasdaq
  • Market Cap
  • RDHL 3.9M
  • SGD 4.4M
  • IPO Year
  • RDHL N/A
  • SGD N/A
  • Fundamental
  • Price
  • RDHL $1.23
  • SGD $1.54
  • Analyst Decision
  • RDHL
  • SGD
  • Analyst Count
  • RDHL 0
  • SGD 0
  • Target Price
  • RDHL N/A
  • SGD N/A
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • SGD 7.0M
  • Earning Date
  • RDHL 08-28-2025
  • SGD 08-22-2025
  • Dividend Yield
  • RDHL N/A
  • SGD N/A
  • EPS Growth
  • RDHL N/A
  • SGD N/A
  • EPS
  • RDHL N/A
  • SGD N/A
  • Revenue
  • RDHL $8,042,999.00
  • SGD $175,906.00
  • Revenue This Year
  • RDHL $381.91
  • SGD N/A
  • Revenue Next Year
  • RDHL N/A
  • SGD N/A
  • P/E Ratio
  • RDHL N/A
  • SGD N/A
  • Revenue Growth
  • RDHL 23.17
  • SGD 253.11
  • 52 Week Low
  • RDHL $1.17
  • SGD $0.65
  • 52 Week High
  • RDHL $15.34
  • SGD $8.02
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • SGD 60.93
  • Support Level
  • RDHL $1.17
  • SGD $1.36
  • Resistance Level
  • RDHL $3.31
  • SGD $2.10
  • Average True Range (ATR)
  • RDHL 0.31
  • SGD 0.26
  • MACD
  • RDHL -0.09
  • SGD 0.08
  • Stochastic Oscillator
  • RDHL 2.80
  • SGD 44.59

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

Share on Social Networks: